Pelthos Therapeutics enters merger agreement to be acquired
Pelthos Therapeutics Inc. announced a definitive agreement to be acquired by Castle Creek Biosciences, Inc. and Paragon Biosciences. The deal, dated October 30, 2026, outlines the details of an all-stock merger.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed